M. Zheng, and L. Song, Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. Cellular & molecular immunology (2020).
 A.C. Walls, Y.-J. Park, M.A. Tortorici, A. Wall, A.T. McGuire, and D. Veesler, Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. bioRxiv (2020) 2020.02.19.956581.
 A. Grifoni, J. Sidney, Y. Zhang, R.H. Scheuermann, B. Peters, and A. Sette, Candidate targets for immune responses to 2019-Novel Coronavirus (nCoV): sequence homology- and bioinformatic-based predictions. bioRxiv (2020) 2020.02.12.946087.
 S.F. Ahmed, A.A. Quadeer, and M.R. McKay, Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses 12 (2020) 254.
 G. Lucchese, Epitopes for a 2019-nCoV vaccine. Cellular & molecular immunology (2020).
 A. Pashov, V. Shivarov, M. Hadzhieva, V. Kostov, D. Ferdinandov, K.-M. Heintz, S. Pashova, M. Todorova, T. Vassilev, T. Kieber-Emmons, L.A. Meza-Zepeda, and E. Hovig, Diagnostic Profiling of the Human Public IgM Repertoire With Scalable Mimotope Libraries. Frontiers in Immunology 10 (2019).
 D. Wrapp, N. Wang, K.S. Corbett, J.A. Goldsmith, C.-L. Hsieh, O. Abiona, B.S. Graham, and J.S. McLellan, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (2020) eabb2507.
 A.C. Walls, X. Xiong, Y.J. Park, M.A. Tortorici, J. Snijder, J. Quispe, E. Cameroni, R. Gopal, M. Dai, A. Lanzavecchia, M. Zambon, F.A. Rey, D. Corti, and D. Veesler, Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell 176 (2019) 1026-1039.e15.
 M. Felder, A. Kapur, J. Gonzalez-Bosquet, S. Horibata, J. Heintz, R. Albrecht, L. Fass, J. Kaur, K. Hu, H. Shojaei, R.J. Whelan, and M.S. Patankar, MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress. Molecular cancer 13 (2014) 129.
 Z. Cao, Y. Wang, Z.-Y. Liu, Z.-S. Zhang, S.-C. Ren, Y.-W. Yu, M. Qiao, B.-B. Zhai, and Y.-H. Sun, Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes. Asian J Androl 15 (2013) 742-746.
 J. Burchell, and J. Taylor-Papadimitriou, Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epithelial Cell Biol 2 (1993) 155-162.
 J. Burchell, S. Gendler, J. Taylor-Papadimitriou, A. Girling, A. Lewis, R. Millis, and D. Lamport, Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer research 47 (1987) 5476-5482.
 E. Petrakou, A. Murray, and M.R. Price, Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 19 Suppl 1 (1998) 21-29.
 D. Zhou, L. Xu, W. Huang, and T. Tonn, Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy. Molecules (Basel, Switzerland) 23 (2018) 1326.
 N. Baumgarth, A two-phase model of B-cell activation. Immunol Rev 176 (2000) 171-80.
 A.F. Popi, I.M. Longo-Maugéri, and M. Mariano, An Overview of B-1 Cells as Antigen-Presenting Cells. Frontiers in immunology 7 (2016) 138-138.
 N. Baumgarth, O.C. Herman, G.C. Jager, L.E. Brown, L.A. Herzenberg, and J. Chen, B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192 (2000) 271-280.
 P.D. Simitsek, D.G. Campbell, A. Lanzavecchia, N. Fairweather, and C. Watts, Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants [see comments]. J Exp Med 181 (1995) 1957-63.
 J. Yang, E. James, M. Roti, L. Huston, J.A. Gebe, and W.W. Kwok, Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals. International immunology 21 (2009) 63-71.
 N. Baumgarth, J.W. Tung, and L.A. Herzenberg, Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 26 (2005) 347-62.
 Y. He, Y. Zhou, H. Wu, B. Luo, J. Chen, W. Li, and S. Jiang, Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. Journal of immunology (Baltimore, Md. : 1950) 173 (2004) 4050-4057.
 I. Thevarajan, T.H.O. Nguyen, M. Koutsakos, J. Druce, L. Caly, C.E. van de Sandt, X. Jia, S. Nicholson, M. Catton, B. Cowie, S.Y.C. Tong, S.R. Lewin, and K. Kedzierska, Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nature medicine (2020).